The blood-brain barrier (BBB) restricts exchanges of soluble factors a
nd cells between the blood and the brain, thus playing a crucial role
in maintenance of cerebral homeostasis. It is composed of the endothel
ial cells that line the cerebral capillaries. Cerebral capillaries hav
e a number of distinctive morphological characteristics, including the
presence of tight intercellular junctions. Also, the cerebral capilla
ries are surrounded by astrocytic projections that exert a positive re
gulatory effect on BBB tightness. One effect of the BBB is that the nu
mber of leukocytes that patrol the central nervous system is far lower
than in peripheral organs. Nevertheless, massive leukocyte infiltrati
on occurs in some disease states: for instance, numerous activated leu
kocytes are found in the cerebral parenchyma in patients with multiple
sclerosis, and HIV encephalitis is probably due to passage of HIV-inf
ected monocytes through the BBB. Compelling evidence has been obtained
that the perivascular astrocytes and microglial cells, as well as the
cerebral endothelial cells, locally produce inflammatory cytokines th
at increase BBB permeability. Advances have also been made in the iden
tification of leukocyte adhesion molecules expressed at the surface of
cerebral endothelial cells. Expression of these molecules is induced
by inflammatory cytokines. Interactions between these adhesion molecul
es and their leukocyte ligands may induce modifications within endothe
lial cells, including cytoskeleton reorganization and opening of inter
cellular junctions, which may allow leukocytes to cross the BBB. It is
to be hoped that the new insights gained into the mechanisms of leuko
cyte penetration through the BBB may help to develop novel treatment s
trategies for neuroinflammatory disorders.